1003319-99-0Relevant articles and documents
Discovery of oxathiapiprolin, a new oomycete fungicide that targets an oxysterol binding protein
Pasteris, Robert J.,Hanagan, Mary Ann,Bisaha, John J.,Finkelstein, Bruce L.,Hoffman, Lisa E.,Gregory, Vann,Andreassi, John L.,Sweigard, James A.,Klyashchitsky, Boris A.,Henry, Yewande T.,Berger, Richard A.
, p. 354 - 361 (2016/01/25)
Oxathiapiprolin is the first member of a new class of piperidinyl thiazole isoxazoline fungicides with exceptional activity against plant diseases caused by oomycete pathogens. It acts via inhibition of a novel fungal target - an oxysterol binding protein - resulting in excellent preventative, curative and residual efficacy against key diseases of grapes, potatoes and vegetables. Oxathiapiprolin is being developed globally as DuPont Zorvec disease control with first registration and sales anticipated in 2015. The discovery, synthesis, optimization and biological efficacy are presented.
AZOCYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE
-
Page/Page column 47, (2011/06/26)
Disclosed are compounds of Formula 1, including all stereoisomers, N oxides, and salts thereof, wherein A, W, X, G, R1, R2, R3, R4, m and n are as defined in the disclosure. Also disclosed are pharmaceutical compositions containing the compounds of Formula 1 and methods for treating a disease or condition mediated by fatty acid amide hydrolase activity comprising applying a therapeutically effective amount of a compound or a composition of the invention
FUNGICIDAL HETERCYCLIC COMPOUNDS
-
Page/Page column 129, (2009/09/05)
Disclosed are compounds of Formula (1), including all geometric and stereoisomers, N-oxides, and salts thereof, formula (1) wherein E, R2, G, Z1, J and n are as defined in the disclosure. Also disclosed are compositions containing th